Ā | Snus use | |
---|---|---|
Outcome and model (total number) | Nonusers | Users |
Myocardial infarction (NĀ =ā20,501) | ||
āTotal number of cases | 852 | 21 |
āAge and sex-adjusted model | 1.00 (reference) | 1.35 (0.87ā2.10) |
āMultivariable model 1ā | 1.00 (reference) | 1.36 (0.87ā2.11) |
Heart failure (NĀ =ā21,130) | ||
āTotal number of cases | 1066 | 14 |
āAge and sex-adjusted model | 1.00 (reference) | 1.04 (0.61ā1.78) |
āMultivariable model 1ā | 1.00 (reference) | 0.92 (0.54ā1.57) |
Atrial fibrillation (NĀ =ā19,852) | ||
āTotal number of cases | 2193 | 43 |
āAge and sex-adjusted model | 1.00 (reference) | 1.33 (0.98ā1.81) |
āMultivariable model 1ā | 1.00 (reference) | 1.29 (0.95ā1.75) |
Total stroke* (NĀ =ā20,620) | ||
āTotal number of cases | 1160 | 24 |
āAge and sex-adjusted model | 1.00 (reference) | 1.57 (1.04ā2.37) |
āMultivariable model 1ā | 1.00 (reference) | 1.53 (1.02ā2.32) |
Total ischemic stroke (NĀ =ā20,620) | ||
āTotal number of cases | 957 | 21 |
āAge and sex-adjusted model | 1.00 (reference) | 1.69 (1.09ā2.63) |
āMultivariable model 1ā | 1.00 (reference) | 1.65 (1.06ā2.57) |
CVD mortality (NĀ =ā18,189) | ||
āTotal number of deaths | 780 | 15 |
āAge and sex-adjusted model | 1.00 (reference) | 1.70 (1.01ā2.87) |
āMultivariable model 1ā | 1.00 (reference) | 1.58 (0.94ā2.67) |